161 related articles for article (PubMed ID: 35172610)
1. Development and validation of an LC-MS/MS method for determination of a novel anticancer agent (CPI-613) in human plasma.
Reddy NR; Reddy V; Boteju A; Boteju L; Voelker T; Liu S; Hu K
Bioanalysis; 2022 Mar; 14(5):253-266. PubMed ID: 35172610
[TBL] [Abstract][Full Text] [Related]
2. Development and Validation of High-Throughput Bioanalytical Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) Method for the Quantification of Newly Synthesized Antitumor Carbonic Anhydrase Inhibitors in Human Plasma.
Abdel-Megied AM; Eldehna WM; Abdelrahman MA; Elbarbry FA
Molecules; 2020 Dec; 25(23):. PubMed ID: 33291270
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of LC-MS/MS methods for the quantification of the novel anticancer agent guadecitabine and its active metabolite β‑decitabine in human plasma, whole blood and urine.
Roosendaal J; Wang K; Rosing H; Lucas L; Gebretensae A; Oganesian A; Schellens JHM; Beijnen JH; Lin ZJ
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Mar; 1109():132-141. PubMed ID: 30754019
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of a bioanalytical method for the simultaneous determination of heroin, its main metabolites, naloxone and naltrexone by LC-MS/MS in human plasma samples: Application to a clinical trial of oral administration of a heroin/naloxone formulation.
Moreno-Vicente R; Fernández-Nieva Z; Navarro A; Gascón-Crespí I; Farré-Albaladejo M; Igartua M; Hernández RM; Pedraz JL
J Pharm Biomed Anal; 2015 Oct; 114():105-12. PubMed ID: 26037158
[TBL] [Abstract][Full Text] [Related]
5. Validation of a sensitive simultaneous LC-MS/MS method for the quantification of novel anti-cancer thiazolidinedione and quinazolin-4-one derivatives in rat plasma and its application in a rat pharmacokinetic study.
Sengottuvelan S; Uppal R; Vuppu S
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jul; 1121():18-27. PubMed ID: 31082683
[TBL] [Abstract][Full Text] [Related]
6. LC-MS/MS assay of fluoropezil and its two major metabolites in human plasma: an application to pharmacokinetic studies.
Guo R; Hu J; Jing J; Liu Y; Li J; Zhou Y; Liu H; Zhou L; Chen X
Bioanalysis; 2022 Jun; 14(11):817-829. PubMed ID: 35735138
[No Abstract] [Full Text] [Related]
7. Simultaneous determination of 11 alkaloids in rat plasma by LC-ESI-MS/MS and a pharmacokinetic study after oral administration of total alkaloids extracted from Naucleaofficinalis.
Wang G; Wang H; Lin Z; Hou L; Wang JY; Sun L
J Ethnopharmacol; 2022 Jan; 282():114560. PubMed ID: 34454053
[TBL] [Abstract][Full Text] [Related]
8. Method development and validation for simultaneous determination of six tyrosine kinase inhibitors and two active metabolites in human plasma/serum using UPLC-MS/MS for therapeutic drug monitoring.
Zhang M; Liu X; Chen Z; Jiang S; Wang L; Tao M; Miao L
J Pharm Biomed Anal; 2022 Mar; 211():114562. PubMed ID: 35124453
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous determination of abiraterone and its five metabolites in human plasma by LC-MS/MS: Application to pharmacokinetic study in healthy Chinese subjects.
Hu Y; Wu J; Jiang X; Chen G; Zhang Y; Si L; Jiang H; Huang J; Huang J
J Pharm Biomed Anal; 2022 Aug; 217():114826. PubMed ID: 35576735
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous quantification of 19 analytes in breast milk by liquid chromatography-tandem mass spectrometry (LC-MS/MS).
Monfort A; Jutras M; Martin B; Boucoiran I; Ferreira E; Leclair G
J Pharm Biomed Anal; 2021 Sep; 204():114236. PubMed ID: 34273657
[TBL] [Abstract][Full Text] [Related]
11. A validated LC-MS/MS method for the simultaneous determination of thalidomide and its two metabolites in human plasma: Application to a pharmacokinetic assay.
Jiang F; Peng X; Cai D; Wen D; Liu Y; Zhi M; Chen J; Hu P; Wang X; Gao Y; Huang M; Gao X; Zhong G
Biomed Chromatogr; 2018 Aug; 32(8):e4240. PubMed ID: 29529709
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of a liquid chromatography and ion spray tandem mass spectrometry method for the quantification of artesunate, artemether and their major metabolites dihydroartemisinin and dihydroartemisinin-glucuronide in sheep plasma.
Duthaler U; Keiser J; Huwyler J
J Mass Spectrom; 2011 Feb; 46(2):172-81. PubMed ID: 21259399
[TBL] [Abstract][Full Text] [Related]
13. A validated LC-MS/MS assay for the simultaneous determination of the anti-leukemic agent dasatinib and two pharmacologically active metabolites in human plasma: application to a clinical pharmacokinetic study.
Furlong MT; Agrawal S; Hawthorne D; Lago M; Unger S; Krueger L; Stouffer B
J Pharm Biomed Anal; 2012 Jan; 58():130-5. PubMed ID: 21982905
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of an LC-MS/MS method to measure the BRAF inhibitors dabrafenib and encorafenib quantitatively and four major metabolites semi-quantitatively in human plasma.
Myszkiewicz MF; Puzanov I; Goey AKL
J Pharm Biomed Anal; 2023 Sep; 234():115594. PubMed ID: 37478552
[TBL] [Abstract][Full Text] [Related]
15. Quantification of tacrolimus and three demethylated metabolites in human whole blood using LC-ESI-MS/MS.
Dubbelboer IR; Pohanka A; Said R; Rosenborg S; Beck O
Ther Drug Monit; 2012 Apr; 34(2):134-42. PubMed ID: 22406653
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous quantification of carbamate insecticides in human plasma by liquid chromatography/tandem mass spectrometry.
Mostafa A; Medley G; Roberts DM; Mohamed MS; Elshanawani AA; Roberts MS; Liu X
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Aug; 879(23):2234-8. PubMed ID: 21723210
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous analysis of oxybutynin and its active metabolite N-desethyl oxybutynin in human plasma by stable isotope dilution LC-MS/MS to support a bioequivalence study.
Sharma P; Patel DP; Sanyal M; Berawala H; Guttikar S; Shrivastav PS
J Pharm Biomed Anal; 2013 Oct; 84():244-55. PubMed ID: 23867086
[TBL] [Abstract][Full Text] [Related]
18. Determination of the sulfate and glucuronide conjugates of levornidazole in human plasma and urine, and levornidazole and its five metabolites in human feces by high performance liquid chromatography-tandem mass spectrometry.
He G; Guo B; Zhang J; Li Y; Wu X; Fan Y; Chen Y; Cao G; Yu J
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Apr; 1081-1082():87-100. PubMed ID: 29518721
[TBL] [Abstract][Full Text] [Related]
19. Bioanalysis of farnesyl pyrophosphate in human plasma by high-performance liquid chromatography coupled to triple quadrupole tandem mass spectrometry and hybrid quadrupole Orbitrap high-resolution mass spectrometry.
Sugimoto H; Iguchi M; Jinno F
Anal Bioanal Chem; 2017 May; 409(14):3551-3560. PubMed ID: 28343347
[TBL] [Abstract][Full Text] [Related]
20. Validation of an LC-MS/MS method for the quantitative determination of the orexin receptor antagonist almorexant and its four primary metabolites in human plasma.
Wagner-Redeker W; Finsterwald I; Dingemanse J
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Mar; 951-952():96-103. PubMed ID: 24531213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
